Drug Type Monoclonal antibody |
Synonyms BAT 1306, BAT-1306 |
Target |
Action inhibitors |
Mechanism PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 2 | China | 21 Jun 2019 | |
HER2 Positive Solid Tumors | Phase 2 | China | 21 Jun 2019 | |
Epstein-Barr virus associated gastric carcinoma | Phase 2 | China | 08 Jan 2019 | |
Bladder Cancer | Phase 1 | China | 04 Jan 2018 | |
Head and Neck Neoplasms | Phase 1 | China | 04 Jan 2018 | |
Kidney Neoplasms | Phase 1 | China | 04 Jan 2018 | |
Melanoma | Phase 1 | China | 04 Jan 2018 | |
Small Cell Lung Cancer | Phase 1 | China | 04 Jan 2018 |